Investors file lawsuit as DOV share price tumbles

Investors have filed a lawsuit against DOV Pharmaceuticals, the US biotechnology firm, in the latest blow to the US biotech initial public offering market.

Slotnick, Shapiro & Crocker, a New York law firm representing investors Hillhouse Capital Management and Turnberry Asset Management, has filed a suit against DOV and its underwriters, CIBC World Markets and Lehman Brothers, for failing to inform investors of last-minute accounting changes.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump